Medical Device Mobile Apps The Biosense Case: FDA Sends First Warning

$1,297.00
Quantity Discounts
1 - 9999
$1,297.00
1 - 9999
$897.00
1 - 9999
$1,297.00
1 - 9999
$897.00
1 - 9999
$1,297.00
1 - 9999
$897.00
1 - 9999
$1,297.00
1 - 9999
$897.00
 
A smartphone app that can analyze urine is a really smart app. Indeed, it isn’t an app at all: It’s a medical device.

Or is it? That’s the question troubling devicemakers everywhere, now that the FDA has made an example of Biosense.

Biosense markets an app called uCheck that checks urine levels of blood, protein and other substances, using dipsticks and an iPhone camera to record and analyze results. The dipsticks are OK; it’s the dipstick-plus-phone combo that’s the problem. Together, asserts the FDA, they constitute a new medical device.

On Sept. 25 the FDA will release its final guidance regulating medical device mobile apps. Some of industry’s concerns will be addressed and some will not.

If you have questions, and who doesn’t… what can you do?

Here’s a great first step: Register now for the one-day virtual conference, Medical Device Mobile Apps.

FDAnews has invited an authoritative FDA voice, Baku Patel of CDRH, plus four top private-sector lawyers and devicemakers for an intensive one-day virtual conference examining this fast-changing area where innovation and regulation collide.

Speakers will lay out how the FDA approaches regulation of mobile medical apps, then tease out the fine points that can mean the difference between FDA approval and a warning letter. You’ll discover:

  • What the FDA means when it uses the word health vs. wellness
  • What the FDA concept of intended use signifies
  • What constitutes an accessory, and which accessories does the FDA regulate?
  • Implications of the Biosense letter and the FDA’s thinking going forward
  • The FDA’s checklist for a successful approval — best practices and red flags every devicemaker must know
  • Obtaining FDA clearance — identifying and addressing safety-and-effectiveness criteria
  • The future of mobile medical apps: How you can work with the FDA to best serve patients
  • And much more

From fast-changing technology to regulatory parameters, conference chair Tim Gee is ideally positioned to shed light on the complexities. Mr. Gee boasts more than 20 years of in-depth research and experience helping medical device firms manage connectivity, and developing and obtaining FDA approval for medical-device apps.

It’d be well worth your time to hop a flight to Washington for this standout event. Fortunately, that’s not necessary. The entire conference is being webcast in real time onto your desktop, saving you precious days away from work.

You’re certain to have questions as the day unfolds. That’s no problem. Shoot ‘em in via email. You’ll have answers by the time this six-hour conference concludes.

You’ll save money, too. Book a conference room or an auditorium and invite as many participants as you like. There’s only one low registration fee per site. It’s easy to add additional locations too, at bargain rates. Simply call (888) 838-5578 in the U.S. or +1 (703) 538-7600 globally to learn about multisite discounts.

Smartphone apps hold immense promise for devicemakers — and thorny new areas of regulation and law too, as the Biosense matter illustrates. On your way to innovation, don’t let regulatory hazards trip you up. Get the answers you need — now.

Register Now


Meet Your Faculty

  • Tim Gee, Principal and Founder of Medical Connectivity Consulting and a principal consultant with Santa Rosa Consulting. He boasts more than 25 years’ experience with workflow automation via integration of medical devices with information systems and enabling technologies. Clients include healthcare providers, manufacturers and early-stage companies. Mr. Gee is 2012 recipient of the American College of Clinical Engineering’s Challenger Award.
  • Brad Thompson, Member, Epstein Becker & Green; General Counsel, mHealth Regulatory Coalition
  • Bakul Patel, Senior Policy Advisor to the Center Director, CDRH, FDA (invited)
  • Kyle Peterson, Director, Regulatory & Corporate Affairs, Calgary Scientific
  • Marian Lee, Partner, King and Spalding

Here’s How It Works

Twenty-four hours prior to the Virtual Conference on Thursday, attendees will receive all presentations.

Then, just log on to the Virtual Conference website and dial a toll-free number, both provided in your registration confirmation. And relax. That’s all there is to it.

Key people throughout your company will benefit from taking part in this event. Best of all, everyone can do so at a cost that won’t break the budget. You pay one single low registration fee per facility, regardless of how many participate. So spread the word.

Don’t take unnecessary risks. Sign up today for this timely learning event.

  • Stress-free! No airport security hassles, no 4 a.m. wakeups, no anonymous hotel rooms. You never even leave your building — not even your own desk.
  • Interactive! Constant opportunities to ask questions and get involved. Send in queries via e-mail ... you’ll have answers before you log off.
  • Up-to-the-minute! Every speaker operates in the real world, in real time. If news breaks on Virtual Conference morning, you’ll hear about it before the session ends.
  • Great value! Spread the word! There’s no limit on number of attendees per site. One low registration fee covers them all. Or register three or more locations for deeper discounts still. Get details here.

Register now


Agenda - Click here to print the agenda.

10:00 a.m. – 10:15 a.m.

Introduction to the Virtual Conference

Tim Gee, Chairperson

10:15 a.m. – 11:00 a.m.

What Does the FDA Consider a Regulated App?  Understanding the FDA’s Final Guidance, Enforcement Discretion and Definition of Accessories
On Sept. 25 the FDA will release its final guidance regulating medical device mobile apps. Some of industry’s concerns will be addressed and some will not. What can developers do now to understand if their product falls under the FDA regulatory radar?  Plus, how is the FDA using “enforcement discretion” for products that might be considered a medical device under FDA regulations.  Brad Thompson — one of the industry’s leading attorneys and strategists for medical device apps  — leads you step-by-step through what the FDA expects from you.  You can’t miss this presentation!

Attendees will learn:

  • How to decipher the scope of the FDA’s regulation of mobile medical apps
  • What the FDA means when it says “health” versus “wellness”
  • The FDA’s concept of intended use — is clarification needed?
  • What accessories are and which ones FDA regulates?
  • When FDA regulates decision-support software found in mobile apps

Brad Thompson, Member, Epstein Becker & Green; General Counsel, mHealth Regulatory Coalition

11:00 a.m. – 11:45 a.m.

FDA’s Use of Enforcement Discretion
Industry estimates that 500 million smartphone users worldwide will be using a healthcare application by 2015.  The FDA has jurisdiction over mobile apps that meet the definition of “device” in section 201(h) of the FD&C Act.  In this presentation, FDA staff will detail how the FDA intends to use this discretion and give examples of what does and does not constitute a device.

Attendees will learn:

  • Implications of the Biosense letter and the FDA’s thinking going forward
  • What’s on the FDA’s checklist for a successful approval — what are best practices and red flags that every firm should know

Bakul Patel, Senior Policy Advisor to the Center Director, CDRH, FDA (invited)

11:45 a.m. – 12:30 p.m.

Break

12:30 p.m. – 1:15 p.m.

Successful FDA Clearance: A Case Study on Designing, Developing and Commercializing a Mobile Medical Application
On March 14, Calgary Scientific received clearance from the FDA to market its medical imaging application, ResolutionMD™ Mobile, as a mobile diagnostic application on Android smartphones and tablets.  This new FDA clearance extended the previous clearance to versions of the solution running on Apple® iPhone® and iPad® devices granted in 2011.  The company also obtained ISO 13485/9001 and CE Mark certifications and four FDA 510(k) clearances.  This presentation will detail the who, what, where, when and how of securing FDA approval.

Attendees will learn:  

  • Obtaining FDA clearance — identifying and addressing the safety and effectiveness criteria; establishing a repeatable process for future clearances
  • Understanding the issues that impact design, usability and end-user implementation
  • Different factors that went into creating and designing Calgary Scientific’s mobile device user interface
  • How to become a strategic supplier — using an app to leverage your company strategy

Kyle Peterson, Director, Regulatory & Corporate Affairs, Calgary Scientific

1:15 p.m. – 2:15 p.m.

Lunch

2:15 p.m. – 3:00 p.m.

Beyond FDA:  Emerging Regulations, Risks and Rewards from FTC, FCC and States
A growing network of federal and state authorities — such as the FDA, FTC, FCC and California — are regulating and taking enforcement action in the mobile health arena.  This presentation provide insights into the complex web of regulations, guidance and enforcement that is shaping mobile health, and provide recommendations for moving forward in this rapidly changing environment.

Attendees will learn:

  • Various FDASIA-driven regulations are finally coming on-line — how do these effect medical devices?
  • To be or not to be:  Examples of mobile apps that are not mobile medical device apps
  • How FTC guidances affect your marketing and privacy disclosures
  • Roundup of state-level actions that are effecting medical device app development

Marian Lee, Partner, King and Spalding

3:00 p.m. – 3:45 p.m.

Driving Adoption of Mobile Apps for Medical Device Connectivity and Remote Healthcare:  Top Trends
The market is flooded with medical device and health-related apps — many of them harmless, but some of them potentially dangerous and in need of regulation.  App developers always tend towards developing cool software but they must understand the risks and the intentions of the devices they create.  This presentation will focus on the top trends influencing the development of apps and provide a regulatory and strategic pathway for potential app developers.

Attendees will learn:

  • Uncovering what constitutes a medical mobile app and the role of apps in medical device systems
  • Reviewing the evolution of hardware platforms and exploring market segmentation
  • Evaluating the key drivers for growth in mobile apps in medical applications
  • Addressing the challenges and barriers to market entry for a medical device manufacturer

Tim Gee, Principal, Medical Connectivity Consulting

3:45 p.m. – 4:00 p.m.

Closing Comments and Adjournment

Tim Gee, Chairperson

  • Product development teams
  • Research and design teams
  • Legal and regulatory affairs
  • Risk management and design operations
  • Manufacturing
  • R&D and engineering
  • QA/QC staff
  • Compliance officers
  • Executive management
  • Outside counsel
Date: Thursday, Oct. 3, 2013
Location: Your office or conference room (no need to travel!)
Time: 10:00 a.m. – 4:00 p.m. EDT
  9:00 a.m. – 3:00 p.m. CDT
  8:00 a.m. – 2:00 p.m. MDT
  7:00 a.m. – 1:00 p.m. PDT
  3:00 p.m. – 9:00 p.m. BST

Send Your Team for Maximum Benefit
Get your team up to speed!

Significant tuition discounts are available for teams of three or
more from the same company. You must register at the same time and
provide a single payment to take advantage of the discount. Register below
by clicking on add to cart and then change your quantity in the shopping cart.
The discount will be calculated automatically.

3-4 attendees – 10%
7-9 attendees – 20%
5-6 attendees – 15%
10+ attendees – 25%

Call (888) 838-5578 in the U.S. or +1 (703) 538-7600
globally with any questions.

Check your local time against the times above. (Washington, D.C. is representative of Eastern time.)

Can't make the scheduled date and time? See the 24/7 ENCORE option described below.

Five Cost-Effective Tuition Options
All participants of the live session are eligible to receive a certificate of attendance.

Payment is required by the date of the Virtual Conference. We accept American Express, Visa and MasterCard. Make checks payable to FDAnews.

Or, register by phone: toll free (888) 838-5578 (inside the U.S.) or +1 (703) 538-7600

Cancellations/Substitutions
Virtual Conference registrations may not be cancelled. Registrants may substitute the 24/7 ENCORE™ audio and Web-based presentations for the live virtual conference at any time. Please contact Customer Service to make any substitutions. No-shows will automatically be sent the 24/7 ENCORE™ login information and speakers’ presentations.